SK&F 102698

N/A

Report date: 2025/03/18 15:41:04
NME

Base Information

Drug NameSK&F 102698
Drug Alias NameSKF-102698SK&F 102698
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine beta-hydroxylase inhibitors
TargetsDopamine beta-hydroxylase
Therapy Area/IndicationsHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsHypertension

Other Information

ATC CodeN/A
Related LinksN/A